Thyroid cancer: pathogenesis and targeted therapy
Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have historically been limited. Recent progress in understanding the pathogenesis of the various subtypes of thyroid cancer has led to increased interest in the development of targeted therapies, with potential stra...
Main Authors: | David A. Liebner, Manisha H. Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-10-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018811419889 |
Similar Items
-
Thyroid eye disease: From pathogenesis to targeted therapies
by: Jin Sook Yoon, et al.
Published: (2022-01-01) -
Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma
by: Jung Guk Kim
Published: (2014-09-01) -
Modern concepts of the molecular pathogenesis of thyroid cancer
by: A. A. Mikhailova, et al.
Published: (2021-07-01) -
Kinase inhibitors in thyroid cancers
by: Vineeth Sukrithan, et al.
Published: (2024-02-01) -
Molecular targeted therapies of aggressive thyroid cancer
by: Silvia Martina eFerrari, et al.
Published: (2015-11-01)